Filing Details

Accession Number:
0001181431-10-062545
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-17 17:27:42
Reporting Period:
2010-12-15
Filing Date:
2010-12-17
Accepted Time:
2010-12-17 17:27:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1338042 Aegerion Pharmaceuticals Inc. AEGR Pharmaceutical Preparations (2834) 202960116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314575 D Marc Beer C/O Aegerion Pharmaceuticals, Inc.
89 Headquarters Plaza, Suite 1212
Morristown NJ 07960
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-15 200 $12.33 105,463 No 4 P Indirect By son
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By son
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 105,263 Direct